Spero Therapeutics, Inc. SPRO
Set alert
1.05 USD +0.01 +0.96%
As of Nov 3, 1:52 PM ET
1.03 Day range 1.06
1.03 52-week range 3.08
- YTD
- -54.94%
- 1 year
- -55.88%
- Open
- 1.04
- Prev close
- 1.04
- Mkt cap
- 61.15M
- Vol
- 150.32K
- Avg vol
- 585.83K
- EPS
- 0.14
- P/E
- 7.50
- Div yield
- 0.00%
More statistics
- Low
- 1.03
- High
- 1.06
- Forward P/E
- -0.83
- Beta
- 0.63
- Short ratio
- 2.08
- Inst. own
- 23.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 1.20
- 200-d avg
- 1.38
- 1y target
- 5.00
15m chart
Built from the cached five-day intraday bars.
Signals (16)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 12:40 PM | 1 hour ago |
| MACD: Sell Signal | Nov 3, 12:25 PM | 1 hour ago |
| SMA: Bearish | Nov 3, 10:40 AM | 3 hours ago |
| SMA: Bullish | Nov 2, 1:10 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 11:25 AM | 1 day ago |
| MACD: Buy Signal | Nov 2, 10:10 AM | 1 day ago |
| RSI: Oversold | Nov 2, 9:40 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:25 PM | 4 days ago |
| RSI: Oversold | Oct 30, 10:25 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 3:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 5 days ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
- Strong buy1
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40667 | -0.60 – -0.27 | 0.96 | -142.4% | 4.13M | -94.4% | 3 |
| Next quarter | -0.265 | -0.33 – -0.20 | -0.24 | -10.4% | 11.00M | +18.7% | 2 |
| Current year | -1.29 | -1.48 – -1.17 | 0.5305 | -343.8% | 36.94M | -64.4% | 3 |
| Next year | -0.91667 | -1.17 – -0.74 | -1.29 | +29.1% | 20.00M | -45.9% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Dec 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Nov 15, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Nov 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2024 | TD Cowen | Upgrade | Hold | Buy |
| Aug 6, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 4, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Mar 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 1, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 26, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 23, 2022 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Aug 15, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 23, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 20, 2022 | Berenberg | Downgrade | Buy | Hold |
| May 17, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| May 4, 2022 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| May 4, 2022 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Apr 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 21, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 1, 2021 | Oppenheimer | Downgrade | Outperform | Perform |
| Jan 22, 2021 | HC Wainwright & Co. | Maintained | — | Buy |